Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Canadian Journal of Cardiology
|
February 21, 2026
Clinical knowns and mechanistic unknowns: cardioprotection and inflammation modulation of GLP-1 receptor agonists and SGLT2 inhibitors
Ellis Y Kim, Matthew J Feinstein
Skeletal Muscle
|
September 22, 2016
Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease
Ellis Y Kim, Patrick Page, Lisa M Dellefave-Castillo, et al.
European Heart Journal. Imaging Methods and Practice
|
July 3, 2025
Anterior mitral valve leaflet length and response to mavacamten in obstructive hypertrophic cardiomyopathy
Danish Saleh, Ellis Y Kim, Kifah Hussain, et al.
Circulation
|
August 6, 2017
Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy
David Y Barefield, Megan J Puckelwartz, Ellis Y Kim, et al.
JCI Insight
|
May 4, 2018
Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers
Eugene J Wyatt, Alexis R Demonbreun, Ellis Y Kim, et al.
The American Journal of Cardiology
|
December 26, 2024
Comparison of Alcohol Septal Ablation With Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Ashraf Samhan, Danish Saleh, Ellis Y Kim, et al.
JCI Insight
|
February 8, 2019
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes
Ellis Y Kim, David Y Barefield, Andy H Vo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 11, 2014
Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair
Kayleigh A Swaggart, Alexis R Demonbreun, Andy H Vo, et al.
Journal of Cardiovascular Development and Disease
|
January 27, 2026
Comparison of Diastolic Function Parameters After Alcohol Septal Ablation and Mavacamten Therapy in Obstructive Hypertrophic Cardiomyopathy
Danish Saleh, Ellis Y Kim, Kifah Hussain, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Canadian Journal of Cardiology
|
February 21, 2026
Clinical knowns and mechanistic unknowns: cardioprotection and inflammation modulation of GLP-1 receptor agonists and SGLT2 inhibitors
Ellis Y Kim, Matthew J Feinstein
Skeletal Muscle
|
September 22, 2016
Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease
Ellis Y Kim, Patrick Page, Lisa M Dellefave-Castillo, et al.
European Heart Journal. Imaging Methods and Practice
|
July 3, 2025
Anterior mitral valve leaflet length and response to mavacamten in obstructive hypertrophic cardiomyopathy
Danish Saleh, Ellis Y Kim, Kifah Hussain, et al.
Circulation
|
August 6, 2017
Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy
David Y Barefield, Megan J Puckelwartz, Ellis Y Kim, et al.
JCI Insight
|
May 4, 2018
Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers
Eugene J Wyatt, Alexis R Demonbreun, Ellis Y Kim, et al.
The American Journal of Cardiology
|
December 26, 2024
Comparison of Alcohol Septal Ablation With Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Ashraf Samhan, Danish Saleh, Ellis Y Kim, et al.
JCI Insight
|
February 8, 2019
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes
Ellis Y Kim, David Y Barefield, Andy H Vo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 11, 2014
Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair
Kayleigh A Swaggart, Alexis R Demonbreun, Andy H Vo, et al.
Journal of Cardiovascular Development and Disease
|
January 27, 2026
Comparison of Diastolic Function Parameters After Alcohol Septal Ablation and Mavacamten Therapy in Obstructive Hypertrophic Cardiomyopathy
Danish Saleh, Ellis Y Kim, Kifah Hussain, et al.
Page
of 1